We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
501
DELISTED
Esperion Therapeutics
ESPR
$16K ﹤0.01%
5,061
-284
-5% -$794
CADL icon
502
Candel Therapeutics
CADL
$978M
$16K ﹤0.01%
1,551
+327
+27% +$2.47K
PDM
503
Piedmont Realty Trust
PDM
$1.21B
$15.5K ﹤0.01%
1,699
-199
-10% -$1.64K
CSTL icon
504
Castle Biosciences
CSTL
$1.01B
$15K ﹤0.01%
631
-17
-3% -$379
MESO
505
Mesoblast
MESO
$2.25B
$15K ﹤0.01%
1,109
+16
+1% +$238
RIGL icon
506
Rigel Pharmaceuticals
RIGL
$909M
$14.9K ﹤0.01%
381
-26
-6% -$802
DEA
507
Easterly Government Properties
DEA
$1.15B
$14.8K ﹤0.01%
595
-59
-9% -$1.38K
IRWD icon
508
Ironwood Pharmaceuticals
IRWD
$704M
$14.5K ﹤0.01%
3,452
-184
-5% -$709
AURA icon
509
Aura Biosciences
AURA
$784M
$14.5K ﹤0.01%
2,043
+627
+44% +$4.49K
FDMT icon
510
4D Molecular Therapeutics
FDMT
$827M
$14.4K ﹤0.01%
1,082
-193
-15% -$1.88K
OMER icon
511
Omeros
OMER
$1.37B
$14.3K ﹤0.01%
1,502
-81
-5% -$964
ALLO icon
512
Allogene Therapeutics
ALLO
$681M
$14.2K ﹤0.01%
6,820
+1,773
+35% +$3.89K
PRME icon
513
Prime Medicine
PRME
$671M
$14.1K ﹤0.01%
3,822
-214
-5% -$711
TRAX
514
First Tracks Biotherapeutics
TRAX
$1.45B
$13.9K ﹤0.01%
+690
New +$12.9K
ZLAB icon
515
Zai Lab
ZLAB
$2.94B
$13.9K ﹤0.01%
729
-144
-16% -$2.85K
PAHC icon
516
Phibro Animal Health
PAHC
$1.55B
$13.8K ﹤0.01%
440
-19
-4% -$802
TECX
517
Tectonic Therapeutic
TECX
$601M
$13.8K ﹤0.01%
400
-15
-4% -$441
SVC
518
Service Properties Trust
SVC
$986M
$13.6K ﹤0.01%
+1,606
New +$12.6K
ACRS icon
519
Aclaris Therapeutics
ACRS
$908M
$13.5K ﹤0.01%
2,553
+134
+6% +$598
CRMD icon
520
CorMedix
CRMD
$657M
$13.1K ﹤0.01%
1,668
-92
-5% -$727
RGNX icon
521
Regenxbio
RGNX
$590M
$12.9K ﹤0.01%
1,075
-53
-5% -$440
CSR
522
Centerspace
CSR
$888M
$12.9K ﹤0.01%
229
-26
-10% -$1.64K
JBGS
523
JBG SMITH
JBGS
$685M
$11.8K ﹤0.01%
803
-144
-15% -$2.13K
ALT icon
524
Altimmune
ALT
$665M
$11.7K ﹤0.01%
3,844
+1,513
+65% +$4.52K
ARVN icon
525
Arvinas
ARVN
$614M
$11.3K ﹤0.01%
1,356
-78
-5% -$727
19 20
21
22 23

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.